TREATMENT OF PATIENTS OVER 50 YEARS OF AGE WITH ACUTE MYELOGENOUS LEUKEMIA WITH A COMBINATION OF RUBIDAZONE AND CYTOSINE-ARABINOSIDE, VINCRISTINE, AND PREDNISONE (ROAP)

被引：0
|
作者：
KEATING, MJ [1 ]
MCCREDIE, KB [1 ]
BENJAMIN, RS [1 ]
BODEY, GP [1 ]
ZANDER, A [1 ]
SMITH, TL [1 ]
FREIREICH, EJ [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOMATH,HOUSTON,TX 77030
来源：
BLOOD | 1981年 / 58卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：584 / 591
页数：8
相关论文
共 50 条
  • [41] SUCCESSFUL RE-INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA WITH CYTOSINE-ARABINOSIDE AND DAUNORUBICIN
    STEIN, RS
    FLEXNER, JM
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2123 - 2124
  • [42] PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    HARRIS, AL
    POTTER, C
    BUNCH, C
    BOUTAGY, J
    HARVEY, DJ
    GRAHAMESMITH, DG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (03) : 219 - 227
  • [43] RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER ELECTIVE CESSATION OF INITIAL TREATMENT - FAILURE OF SUBSEQUENT TREATMENT WITH CYCLOPHOSPHAMIDE, CYTOSINE-ARABINOSIDE, VINCRISTINE AND PREDNISONE (COAP)
    SALLAN, SE
    HITCHCOCKBRYAN, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (05): : 455 - 462
  • [44] TREATMENT OF THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE
    ERNST, TJ
    ROSENTHAL, DS
    GRIFFIN, JD
    CANELLOS, GP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06): : 623 - 626
  • [45] LOW-DOSE CYTOSINE-ARABINOSIDE TREATMENT FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN ELDERLY PATIENTS
    TILLY, H
    CASTAIGNE, S
    BORDESSOULE, D
    SIGAUX, F
    DANIEL, MT
    MONCONDUIT, M
    DEGOS, L
    CANCER, 1985, 55 (08) : 1633 - 1636
  • [46] The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: Rational and design of the French trials
    Guilhot, F
    Guerci, A
    Fiere, D
    Harousseau, JL
    Maloisel, F
    Bouabdallah, R
    Guyotat, D
    Rochant, H
    Najman, A
    Nicolini, F
    Colombat, P
    Abgrall, JF
    Ifrah, N
    Briere, J
    Bauters, F
    Navarro, M
    Morice, P
    Bordessoule, D
    Vilque, JP
    Desablens, B
    Tertian, G
    Blanc, M
    Chastang, C
    Tanzer, J
    BONE MARROW TRANSPLANTATION, 1996, 17 : S29 - S31
  • [47] COMPARISON OF CYTOSINE-ARABINOSIDE AND THIOGUANINE (CAT) AND VINCRISTINE, AMETHOPTERIN, 6-MERCAPTOPURINE AND PREDNISONE (VAMP) THERAPY IN ADULT ACUTE LEUKEMIA (AAL)
    CROWELL, E
    KEIMOWITZ, R
    PISCIOTTA, A
    SCHLOESSER, L
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (01): : 109 - 109
  • [48] RATIONALES FOR A PHARMACOLOGICALLY OPTIMIZED TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA WITH CYTOSINE-ARABINOSIDE
    HEINEMANN, V
    JEHN, U
    LEUKEMIA, 1990, 4 (11) : 790 - 796
  • [49] ORAL IDARUBICIN PLUS CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA IN ELDERLY PATIENTS
    PAGANO, L
    SICA, S
    MARRA, R
    VOSO, MT
    STORTI, S
    DIMARIO, A
    LEONE, G
    HAEMATOLOGICA, 1991, 76 (06) : 517 - 518
  • [50] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - CONTRIBUTIONS TO OUTCOME OF CLINICAL AND LABORATORY ATTRIBUTES
    CURTIS, JE
    MESSNER, HA
    MINDEN, MD
    MINKIN, S
    MCCULLOCH, EA
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 532 - 543
12345